(Q43905055)

27 November 2017

Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia (English)

1 reference

27 November 2017

0 references

hepatocellular carcinoma

1 reference

8

Hainaut P

1 reference

27 November 2017

1

Kirk GD

1 reference

27 November 2017

4

Goedert JJ

1 reference

27 November 2017

Camus-Randon AM

2

1 reference

27 November 2017

Mendy M

3

1 reference

27 November 2017

Merle P

5

1 reference

27 November 2017

Trépo C

6

1 reference

27 November 2017

Bréchot C

7

1 reference

27 November 2017

Montesano R

9

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Journal of the National Cancer Institute

27 November 2017

1 reference

27 November 2017

92

1 reference

27 November 2017

148-153

1 reference

27 November 2017

2

1 reference

Estimates of the worldwide incidence of 25 major cancers in 1990.

27 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Hepatocellular carcinoma: from gene to public health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

The first 2 years of the Gambian National Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Persistent hepatitis B virus infection and hepatoma in The Gambia, west Africa. A case-control study of 140 adults and their 603 family contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Risk factors for transmission of hepatitis B virus to Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Microsatellite alterations in plasma DNA of small cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Microsatellite alterations in serum DNA of head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Isolation and characterization of DNA from the plasma of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Genotyping by mass spectrometric analysis of short DNA fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Sequence specificity in aflatoxin B1--DNA interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Mapping the binding site of aflatoxin B1 in DNA: systematic analysis of the reactivity of aflatoxin B1 with guanines in different DNA sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Base substitution mutations induced by metabolically activated aflatoxin B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Mutational properties of the primary aflatoxin B1-DNA adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F92.2.148

21 January 2018

Identifiers

DOI

10.1093/JNCI/92.2.148

1 reference

27 November 2017

1 reference